ASO作者反思：前列腺癌根治术后淋巴结阳性且无PSA持续存在的治疗选择 - Suppr

Suppr

超能文献

ASO Author Reflections: Treatment Choice for Lymph Node-Positive Prostate Cancer with No PSA Persistence After Radical Prostatectomy.

作者信息

Shiota Masaki, Kimura Takahiro, Nishiyama Naotaka, Kitamura Hiroshi, Eto Masatoshi

机构信息

Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.

出版信息

Ann Surg Oncol. 2024 Jun;31(6):3906-3907. doi: 10.1245/s10434-024-15088-0. Epub 2024 Feb 19.

DOI:10.1245/s10434-024-15088-0

PMID:38372867

Abstract

摘要

相似文献

ASO Author Reflections: Treatment Choice for Lymph Node-Positive Prostate Cancer with No PSA Persistence After Radical Prostatectomy.ASO作者反思：前列腺癌根治术后淋巴结阳性且无PSA持续存在的治疗选择

Ann Surg Oncol. 2024 Jun;31(6):3906-3907. doi: 10.1245/s10434-024-15088-0. Epub 2024 Feb 19.

Prognostic Assessment in Lymph Node-Positive Prostate Cancer Without Prostate-Specific Antigen Persistence After Radical Prostatectomy: An Editorial Commentary.前列腺癌根治术后淋巴结阳性且无前列腺特异性抗原持续存在患者的预后评估：一篇编辑评论

Ann Surg Oncol. 2024 Jun;31(6):3590. doi: 10.1245/s10434-024-15110-5. Epub 2024 Feb 27.

Prognostication in Lymph Node-Positive Prostate Cancer with No PSA Persistence After Radical Prostatectomy.根治性前列腺切除术后 PSA 持续阴性的淋巴结阳性前列腺癌的预后。

Ann Surg Oncol. 2024 Jun;31(6):3872-3879. doi: 10.1245/s10434-024-14999-2. Epub 2024 Feb 14.

[Extended sentinel lymph node dissection in radical prostatectomy for prostate cancer: a study in the Kiel risk population].[前列腺癌根治性前列腺切除术中扩大前哨淋巴结清扫术：基尔风险人群的一项研究]

Urologe A. 2008 Mar;47(3):299-303. doi: 10.1007/s00120-008-1652-2.

Outcomes after radical prostatectomy for patients with clinical stages T1-T2 prostate cancer with pathologically positive lymph nodes in the prostate-specific antigen era.在 PSA 时代，对临床分期为 T1-T2 前列腺癌且前列腺特异性抗原阳性淋巴结的患者进行根治性前列腺切除术的结果。

Urol Oncol. 2013 Nov;31(8):1441-7. doi: 10.1016/j.urolonc.2012.03.006. Epub 2012 Apr 18.

The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.根治性前列腺切除术后前列腺特异性抗原持续存在对预测淋巴结阳性前列腺癌患者临床进展和癌症特异性死亡率的作用。

Eur Urol. 2016 Jun;69(6):1142-8. doi: 10.1016/j.eururo.2015.12.010. Epub 2015 Dec 31.

Targeted salvage lymphadenectomy in patients treated with radical prostatectomy with biochemical recurrence: complete biochemical response without adjuvant therapy in patients with low volume lymph node recurrence over a long-term follow-up.接受根治性前列腺切除术后出现生化复发的患者的靶向挽救性淋巴结清扫术：长期随访中，低容量淋巴结复发患者在无辅助治疗情况下实现完全生化缓解。

BMC Urol. 2015 Feb 21;15(1):10. doi: 10.1186/s12894-015-0004-y.

Per-operative frozen section examination of pelvic nodes is unnecessary for the majority of clinically localized prostate cancers in the prostate-specific antigen era.

Int J Urol. 2000 Aug;7(8):281-6. doi: 10.1046/j.1442-2042.2000.00191.x.

Which Patients with Prostate Cancer and Lymph Node Uptake at Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography/Computerized Tomography Scan Are at a Higher Risk of Prostate-specific Antigen Persistence After Radical Prostatectomy? Identifying Indicators of Systemic Disease by Integrating Clinical, Magnetic Resonance Imaging, and Functional Imaging Parameters.哪些接受术前前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描检查时存在淋巴结摄取的前列腺癌患者在根治性前列腺切除术后前列腺特异性抗原持续存在的风险更高？通过整合临床、磁共振成像和功能成像参数来确定系统性疾病的指标。

Eur Urol Oncol. 2024 Apr;7(2):231-240. doi: 10.1016/j.euo.2023.08.010. Epub 2023 Sep 9.

Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy.前列腺癌患者中盆腔淋巴结阳性的发生率、前列腺特异性抗原（PSA）水平≤10 ng/mL且活检Gleason评分≤6的情况及其对根治性前列腺切除术后无PSA进展生存期的影响。

BJU Int. 2006 Jun;97(6):1173-8. doi: 10.1111/j.1464-410X.2006.06166.x.

引用本文的文献

Ann Surg Oncol. 2024 Jun;31(6):3590. doi: 10.1245/s10434-024-15110-5. Epub 2024 Feb 27.

本文引用的文献

Current Status and Future Perspective on the Management of Lymph Node-Positive Prostate Cancer after Radical Prostatectomy.前列腺癌根治术后淋巴结阳性患者管理的现状与未来展望

Cancers (Basel). 2022 May 30;14(11):2696. doi: 10.3390/cancers14112696.

Radiotherapy plus androgen deprivation therapy for prostate-specific antigen persistence in lymph node-positive prostate cancer.放化疗联合雄激素剥夺疗法治疗淋巴结阳性前列腺癌中前列腺特异抗原持续存在。

Cancer Sci. 2022 Jul;113(7):2386-2396. doi: 10.1111/cas.15383. Epub 2022 May 17.

Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer-Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta-analysis.镓 68 前列腺特异性膜抗原正电子发射断层扫描在晚期前列腺癌中的应用——更新的诊断效用、敏感性、特异性和前列腺特异性膜抗原阳性病变的分布：系统评价和荟萃分析。

Eur Urol. 2020 Apr;77(4):403-417. doi: 10.1016/j.eururo.2019.01.049. Epub 2019 Feb 14.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验